NCT05245149

Brief Summary

The main objective of this study is to evaluate the dose efficiency of coronary CT angiography (CTA) using a photon counting detector CT (PCD-CT) with the dose efficiency of coronary CT angiography of prior CT generations. 100 patients with a clinical indication for coronary CT angiography will be prospectively enrolled and undergo coronary CTA on a PCD-CT. For comparison, a matched retrospective cohort of 100 patients will be created who had undergone on a prior scanner generation (retrospective cohort).

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2021

Completed
7 months until next milestone

First Posted

Study publicly available on registry

February 17, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

February 20, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
Last Updated

February 17, 2022

Status Verified

July 1, 2021

Enrollment Period

1.5 years

First QC Date

July 15, 2021

Last Update Submit

February 8, 2022

Conditions

Keywords

Spectral CTMulti-Energy CTPhoton Counting Detector CTPCD-CT

Outcome Measures

Primary Outcomes (4)

  • Intraluminal Enhancement of Coronary Arteries

    measured on thin-slice reconstructions, in Hounsfield units

    1 year

  • Image Noise

    measured on thin-slice reconstructions, in Hounsfield units

    1 year

  • Overall subjective image quality

    as assessed by board-certified and speciality-trained radiologists on a 5-point Likert scale

    1 year

  • Dose-Length Product (DLP)

    Integrative descriptor for the x-ray dose applied during acquisition; can be read out from the scan protocol.

    1 year

Secondary Outcomes (1)

  • Diagnostic Accuracy of Coronary Artery Stenosis Assessment in Comparison with invasive catheter angiography

    1 year

Study Arms (2)

Prospective Cohort

Patients with a clinical indication for coronary CT angiography will undergo this scan on a photon counting detector CT (PCD-CT).

Diagnostic Test: Cardiac CTA on a photon-counting detector CT (PCD-CT)

Retrospective Cohort

For comparison, a matched retrospective cohort will be created of patients who had undergone coronary CT angiography on prior CT scanner generations (with energy-integrating detector CT, EID-CT)

Diagnostic Test: Cardiac CTA on a regular CT with Energy-Integrating Detector (EID-CT)

Interventions

Cardiac CTA will be performed on a dual-source photon-counting CT

Prospective Cohort

Cardiac CTA was performed on a dual-source CT with regular energy-integrating detector (EID-CT)

Retrospective Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who are at least 18 years of age with a clincially indication for a coronary CTA scan. Indication ('justified indication' according to German/European radiation protection law) must be confirmed by a board-certified radiologist.

You may qualify if:

  • indication for coronary CTA confirmed by board-certified radiologist ('justified indication' according to German/European radiation protection law) AND
  • patient (is able to give informed consent and) has given informed consent.

You may not qualify if:

  • contraindications to (iodine based) iv contrast material: known allergy to iodine-based iv contrast, acute or high-grade chronic kidney insufficiency with an estimated glomerular filtration rate \< 30 ml/min/1.73 m², latent or manifest hyperthyroidism
  • known or suspected pregnancy
  • lactating mothers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Florian Schwarz, MD

    University Hospital Augsburg

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2021

First Posted

February 17, 2022

Study Start

February 20, 2022

Primary Completion

August 30, 2023

Study Completion

August 30, 2024

Last Updated

February 17, 2022

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will share

We plan to share individual participant data upon request (pending final approval by the data protection officer of the university hospital).

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Requests for sharing individual participant data will be considered at the time of publication of the first manuscript containing result data.
Access Criteria
We plan to share data on request at this point in time.